Study Summary
This trial will test if extending sleep can help reduce risk factors for cardiovascular disease and improve health behaviors in adults with hypertension and short sleep duration.
- High Blood Pressure
- Short Sleep Duration
Treatment Effectiveness
Effectiveness Progress
Study Objectives
0 Primary · 2 Secondary · Reporting Duration: 12 months
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Behavioral sleep extension group
1 of 1
Experimental Treatment
120 Total Participants · 1 Treatment Group
Primary Treatment: Sleep extension intervention · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 65 · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is recruitment for this research endeavor still open?
"The clinicaltrials.gov webpage confirms that this experiment is still actively recruiting participants, with the initial post date of March 30th 2021 and most recent update on July 20th 2022." - Anonymous Online Contributor
Who meets the criteria to be part of this clinical trial?
"The current clinical trial is accepting 120 adult patients who have been diagnosed with hypertension and can meet the following criteria: 18-65 years of age, 8 hours or less in bed per night, no more than 7 hours asleep based on actigraphy data and must own a smartphone." - Anonymous Online Contributor
Is there an age restriction for participation in this clinical study?
"This medical trial is open to subjects aged between 18 and 65." - Anonymous Online Contributor
How many people are taking part in this clinical experiment?
"That is correct. Clinicaltrials.gov confirms that this investigation, which was first posted on March 30th 2021, continues to be actively recruiting participants. The research team needs 120 people from a single medical centre for the trial to proceed." - Anonymous Online Contributor